Učitavanje...
Immune Checkpoint Inhibitor‐Associated Myocarditis
Immune checkpoint inhibitors (ICIs) are approved for a wide range of malignancies. They work by priming the immune system response to cancer and have changed the landscape of available cancer treatments. As anticipated, modulation of the regulatory controls in the immune system with ICIs results in...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156176/ https://ncbi.nlm.nih.gov/pubmed/29802219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0130 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|